Fiche société
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Traitements, essais et publications liés.
Traitements7programmes
Essais5liés
Publications2liées
SourceDBlocale
Traitements
7| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| Vagus nerve stimulationVagus nerve stimulation is thought to reduce sympathetic nerve outflow and so can improve sympathetic hyperactivity in fibromyalgia patients. We aimed in the current study, to evaluate the effect of the cervical transcutaneous vagus nerve stimulation in comparison to conventional medical treatment in Egyptian fibromyalgia patients. | Épilepsie, Myopathies, SEP | Non applicable | À vérifier | Belgium | À vérifier |
| Xeomin Injectable Product1. To show that repeated injections of higher doses of botulinum toxin are significantly more effective than the injection of unique, lower doses, on gait function. 2. To describe the effect of repeated injections of botulinum toxin on the muscle structure in terms of volume, fat accumulation and fibrosis, by means of MRI studies | Myopathies | NA | À vérifier | Belgium | À vérifier |
| Xeomin Injectable Product1. To show that repeated injections of higher doses of botulinum toxin are significantly more effective than the injection of unique, lower doses, on gait function. 2. To describe the effect of repeated injections of botulinum toxin on the muscle structure in terms of volume, fat accumulation and fibrosis, by means of MRI studies | Myopathies | NA | À vérifier | Belgium | À vérifier |
| Vagus nerve stimulationVagus nerve stimulation is thought to reduce sympathetic nerve outflow and so can improve sympathetic hyperactivity in fibromyalgia patients. We aimed in the current study, to evaluate the effect of the cervical transcutaneous vagus nerve stimulation in comparison to conventional medical treatment in Egyptian fibromyalgia patients. | Myopathies | Non applicable | À vérifier | Egypt | À vérifier |
| Vagus nerve stimulationVagus nerve stimulation is thought to reduce sympathetic nerve outflow and so can improve sympathetic hyperactivity in fibromyalgia patients. We aimed in the current study, to evaluate the effect of the cervical transcutaneous vagus nerve stimulation in comparison to conventional medical treatment in Egyptian fibromyalgia patients. | SEP | Non applicable | À vérifier | China | À vérifier |
| Vagus nerve stimulationVagus nerve stimulation is thought to reduce sympathetic nerve outflow and so can improve sympathetic hyperactivity in fibromyalgia patients. We aimed in the current study, to evaluate the effect of the cervical transcutaneous vagus nerve stimulation in comparison to conventional medical treatment in Egyptian fibromyalgia patients. | SEP | Non applicable | À vérifier | À vérifier | |
| Vagus nerve stimulationVagus nerve stimulation is thought to reduce sympathetic nerve outflow and so can improve sympathetic hyperactivity in fibromyalgia patients. We aimed in the current study, to evaluate the effect of the cervical transcutaneous vagus nerve stimulation in comparison to conventional medical treatment in Egyptian fibromyalgia patients. | Épilepsie | Non applicable | À vérifier | Belgium | À vérifier |
Essais cliniques
5| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Vagus nerve stimulation | Épilepsie | Non applicable | NCT07909486 | VNS — Identification of Biomarkers for Vagus Nerve Stimulation in Patients With Refractory Epilepsy | RECRUITING |
| Vagus nerve stimulation | SEP | Non applicable | NCT07310381 | Vagus Nerve Stimulation (VNS) Electroencephalogram (EEG) Protocol Supplement | NOT_YET_RECRUITING |
| Vagus nerve stimulation | SEP | Non applicable | NCT06923007 | Advant — Alzheimer's Disease Treated With Vagus Nerve Stimulation | RECRUITING |
| Vagus nerve stimulation | Myopathies | Non applicable | NCT06237595 | Vagus Nerve Stimulation in Fibromyalgia | COMPLETED |
| Xeomin Injectable Product | Myopathies | NA | NCT04544280 | Effect of Repeated Injections of Higher Doses of Botulinum Toxin on Lower Limb of Spastic Hemiplegic Patients on Gait. | COMPLETED |
Publications
2| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Xeomin Injectable Product | CACNA1C -Related Channelopathy Presenting With Adult-Onset Combined Dystonia-Parkinsonism: A Novel Neurological Presentation. | American journal of medical genetics. Part A | ||
| Vagus nerve stimulation | Vagus nerve stimulation as an add-on therapy in patients with epilepsy: a prospective, multicenter, real-world study in China. | Acta epileptologica |